Cytokinetics (CYTK) Misses Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $79.17 --0%
Revenue Growth %: -75.4%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -75.4%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q1 EPS of ($0.54), $0.07 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $8.5 million versus the consensus estimate of $6.86 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Prosperity Bancshares (PB) Reiterated at Overweight by Cantor Fitzgerald as Estimates Revised
- Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
